Feature|Podcasts|October 25, 2024
Fake Weight Loss Drugs: Growing Threat to Consumer Health
Author(s)Miranda Schmalfuhs
In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
Advertisement
UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss:
- Counterfeit weight loss drugs (particularly fake Ozempic) and potential health risks
- What can be done to raise awareness among consumers about the dangers of counterfeit medications
- Ways increase access to legitimate weight loss medications, especially for those in underserved communities
- and much more!
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Industry’s Communication and Engagement with FDA
2
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
3
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
4
Pharmaceutical Executive Daily: Eli Lilly Acquires Engage Bio
5